We believe that our patented “active ingredient” Dermzea™ may provide
therapeutic benefits in the following topical areas – for both
humans and, in some cases, animals:

  • Contact Dermatitis

  • Poison Ivy/Oak

  • Rash & Itch

  • Razor Burn

  • Sunburn/UV/Thermal burns

  • Radiation Burns/Dermatitis

  • Psoriasis

  • Shingles

  • Eczema

  • Rosacea

  • Insect bites and stings

  • Many other skin conditions...

 

OTHER THERAPEUTIC APPLICATIONS

Outside of the skincare area HealthAide, Inc. believes it has additional potential therapeutic applications for which there is some relevant scientific evidence and indications.

These are:

  • Osteoporosis treatment: New digital imagery of an earlier Oklahoma Medical Research Foundation mouse bone study (ingesting our compound for 40 weeks) shows bone density growth.

  • Heart attack and stroke prevention:A swine study at Oklahoma State University demonstrates our compound’s anti-platelet (blood thinning) characteristics that could be useful in heart attack and stroke prevention.

  • Treatment for hypocalcemia: Mass spectral data demonstrating calcium binding to the bio-active dipeptide ester metabolite suggests enhanced calcium bioavailability hypocalcemia treatment.


Interested parties should contact: Dr. Tony Hugli, CEO, HealthAide, Inc.
(858) 597-3892 drhugli@DermaZaide.com

 
Home
About Us
Technology
Purchase Products
Applications
Read Testimonials
Submit A Testimonial
Partnership Opportunities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.